Google creates drug development company

Google parent Alphabet has launched a new drug discovery and development subsidiary.Isomorphic Labs

will use research from DeepMind, a London-based artificial intelligence lab also owned and operated by Alphabet.

At this time, details related toIsomorphic Labs, pretty sparse. However, this is not Alphabet's first foray into the medical field. The company's divisions are already researching various aspects of human health. Among them the companyVerily, which is working on projects ranging from surgical robots to contact lenses that monitor glucose levels in diabetics. Another projectCalico, sets an ambitious goal – overcome aging.

Isomorphic Labs will focus exclusively ondrug discovery and new technologies that can help in drug development. The newly created company said its goal – “rethink” the process of developing new drugs using an artificial intelligence-based approach.

A recent study found that it costs an average of $ 1.3 billion to create a new pharmaceutical product. Most of this amount is related to the development process itself.

Source:engadget

Pictures: PublicDomainPictures

</ p>